In an NHLBI-funded study. that could help advance the field of regenerative medicine for years to come, the Interdisciplinary Stem Cell Institute at the Miller School has found that mesenchymal stem cells, whether from patients or donors, can treat people whose hearts were previously damaged and scarred after a heart attack.
Media Coverage
|
University of Miami Miller School of Medicine